We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-16.68%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$63B
AUM Growth
-$15.8B
Cap. Flow
-$523M
Cap. Flow %
-0.83%
Top 10 Hldgs %
24.77%
Holding
3,865
New
199
Increased
1,422
Reduced
1,761
Closed
372

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Healthcare 9.23%
3 Financials 8.29%
4 Industrials 5.85%
5 Communication Services 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARO
3776
DELISTED
Carolina Financial Corp.
CARO
-5,487
Closed -$237K
BDXA
3777
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
-16,376
Closed -$1.07M
RARX
3778
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-11,621
Closed -$545K
CTST
3779
DELISTED
CannTrust Holdings Inc. Common Share
CTST
-10,325
Closed -$10K
WAAS
3780
DELISTED
AquaVenture Holdings Limited
WAAS
-108,279
Closed -$2.94M
BCRH
3781
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
-77,306
Closed -$530K
AYR
3782
DELISTED
Aircastle Ltd
AYR
-13,942
Closed -$446K
INAP
3783
DELISTED
Internap Corporation
INAP
-47,582
Closed -$52K
INST
3784
DELISTED
Instructure, Inc.
INST
-7,011
Closed -$338K
PEGI
3785
DELISTED
Pattern Energy Group Inc. Class A
PEGI
-50,477
Closed -$1.35M
INXN
3786
DELISTED
Interxion Holding N.V.
INXN
-6,540
Closed -$548K
ZAYO
3787
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-13,138
Closed -$455K
FOMX
3788
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-27,800
Closed -$93K
INF
3789
DELISTED
BROOKFIELD GLOBAL LISTED INFRASTRUCTURE INCOME FUND INC.
INF
-75,296
Closed -$1.05M
AVEO
3790
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-3,330
Closed -$21K
DWAQ
3791
DELISTED
Invesco DWA NASDAQ Momentum ETF
DWAQ
-6,297
Closed -$806K
DWTR
3792
DELISTED
Invesco DWA Tactical Sector Rotation ETF
DWTR
-9,763
Closed -$320K
GHII
3793
DELISTED
Invesco S&P High Income Infrastructure ETF
GHII
-22,173
Closed -$635K
LTS
3794
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
-71,568
Closed -$249K
RWW
3795
DELISTED
Invesco S&P Financials Revenue ETF
RWW
-3,347
Closed -$247K
BLPH
3796
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-1,635
Closed -$9K
CBPX
3797
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
-16,667
Closed -$607K
LPT
3798
DELISTED
Liberty Property Trust
LPT
-5,847
Closed -$351K
ABDC
3799
DELISTED
Alcentra Capital Corp
ABDC
-46,253
Closed -$419K
ACHN
3800
DELISTED
Achillion Pharmaceuticals
ACHN
-27,216
Closed -$164K

Similar funds

Raymond James & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Raymond James & Associates held 3,865 positions worth $63B, down 20% from $78.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2020 filing shows 199 new, 1,422 increased, 1,761 reduced and 372 closed positions. Its largest new stake was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M. The largest sale was Carnival Corporation Ltd, an estimated $106M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2020 buy was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2020, an estimated $220M increase.
  • Raymond James & Associates's biggest Q1 2020 reduction was Carnival Corporation Ltd, cutting an estimated $106M.
  • Raymond James & Associates fully exited State Street SPDR Portfolio S&P 400 Mid Cap ETF in Q1 2020, selling an estimated $36.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $63B portfolio in Q1 2020.
  • Raymond James & Associates opened 199 new positions and closed 372 in Q1 2020.
  • Raymond James & Associates's portfolio value fell 20% quarter-over-quarter to $63B.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.